financetom
Business
financetom
/
Business
/
Federal Bank Q2 net profit slips 26% to Rs 308 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Federal Bank Q2 net profit slips 26% to Rs 308 crore
Oct 16, 2020 6:18 AM

Federal Bank on Friday reported a 26 percent decline in its net profit at Rs 308 crore in the quarter ended September 2020, on account of higher provisions. The private sector lender had posted a net profit of Rs 417 crore during the July-September quarter a year ago.

Total income during the said period rose by 9 percent to Rs 3,997 crore as against Rs 3,675 crore in the same quarter of 2019-20, Federal Bank said in a regulatory filing.

Interest income grew 7 percent to Rs 3,488 crore from Rs 3,254 crore. Its gross non-performing assets (NPAs) fell to 2.84 percent of the gross advances by end of September 2020 as against 3.07 percent a year ago. In value terms, it stood at Rs 3,552.19 crore as against Rs 3,612.11 crore. Net NPAs came down to 0.99 per cent (Rs 1,218.14 crore) as against 1.59 percent (Rs 1,843.64 crore).

Bank’s provisions for bad loans and contingencies were raised to Rs 592.06 crore for the quarter ended September as against Rs 251.77 crore parked aside for the corresponding period a year ago. Federal Bank’s shares were trading 0.10 percent down at Rs 51.70 apiece on the BSE.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Accenture forecasts annual revenue below estimates
Accenture forecasts annual revenue below estimates
Sep 27, 2024
Sept 26 (Reuters) - Accenture ( ACN ) forecast annual revenue below Wall Street estimates on Thursday, as ongoing reductions in enterprise spending continue to weigh on the professional services sector. The company said it expects to report annual revenue growth between 3% and 6%, the midpoint of which was below the analysts' average estimate of a 5.9% growth, according...
Astera Labs Insider Sold Shares Worth $3,475,721, According to SEC Filing
Astera Labs Insider Sold Shares Worth $3,475,721, According to SEC Filing
Sep 27, 2024
04:22 PM EDT, 09/19/2024 (MT Newswires) -- Gajendra Sanjay, Director, on September 17, 2024, sold 76,701 shares in Astera Labs ( ALAB ) for $3,475,721. Following the Form 4 filing with the SEC, Gajendra Sanjay has control over a total of 3,559,335 shares of the company, with 2,704,335 shares held directly and 855,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629724000030/xslF345X05/wk-form4_1726777127.xml Price: 47.18,...
Accenture unveils $4 billion share buyback as AI powers strong quarterly revenue
Accenture unveils $4 billion share buyback as AI powers strong quarterly revenue
Sep 27, 2024
(Reuters) -IT services firm Accenture ( ACN ) on Thursday unveiled a $4.0 billion share buyback and reported better-than-expected fourth-quarter revenue thanks to demand from companies looking to adopt generative artificial intelligence technology. Shares of the company were up nearly 7% in premarket trading. The Dublin-based company reported fourth-quarter revenue of $16.41 billion, compared with analysts expectations of $16.38 billion,...
Axonics Receives Regulatory Approval in Australia for R20 System
Axonics Receives Regulatory Approval in Australia for R20 System
Sep 27, 2024
06:49 AM EDT, 09/26/2024 (MT Newswires) -- Axonics ( AXNX ) said Thursday that Australia's Therapeutic Goods Administration has approved the marketing of the company's R20 rechargeable sacral neuromodulation system as a treatment for adults suffering from overactive bladder and fecal incontinence. The company said it expects to start sales of the R20 in Australia in November. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved